The Preston Robert Tisch Brain Tumor Center at Duke combines the resources of a leading research program with a commitment to offer the best in patient care.

As an integral part of the Duke Cancer Institute, our patients benefit directly from our continuing research into new ways to tackle brain, skull base, and central nervous system tumors; from finding ways to selectively target the tumors to creating new agents designed to destroy cancer.

The number of our patients who survive long-term is steadily increasing.

Sophisticated Treatment to Fight Brain Tumors

We offer experimental treatments -- most developed in our own laboratories -- to subdue aggressive brain tumors, overcome drug-resistant tumors, and manipulate the genes and proteins that fuel a tumor’s growth.

The treatment plan for a brain tumor depends on the tumor type as well as its grade, location, and size. The prognosis (expected outcome) also depends upon the patient’s general health, whether the tumor can be removed surgically, whether any cancer cells remain after surgery, and whether the tumor is new or recurrent.

Our team of neuro-oncologists, neurosurgeons, and surgical oncologists work together to diagnose and treat tumors surgically. Using state-of-the-art surgical techniques, Duke Cancer Institute specialists are able to pinpoint the exact location of the tumor and monitor brain function during surgery to reduce negative effects.

Radiation therapy, radiosurgery, and fractionated radiotherapy are available, guided by the most advanced imaging technology available.

Duke Cancer Institute patients have access to a number of innovative treatments through clinical trials, including immunotherapy techniques and chemotherapy to fight brain tumors.

Among our novel therapies that were developed in our laboratories are radio-labeled monoclonal antibodies to fight high-grade glioma and dendritic cell vaccines to eradicate malignant brain tumors. Our clinical teams have been instrumental in combining conventional chemotherapies with targeted therapies, such as temozolomide plus 06BG and Avastin, to battle malignant glioma.

Recognized for Outstanding Care

The Preston Robert Tisch Brain Tumor Center at Duke is one of the largest and most successful centers in the world.

We also offer many support services and resources aimed at making the treatment process easier for patients and their families.

Appointments

Learn how to make an appointment with the Duke Cancer Institute.